- 期刊
Effects of Neoadjuvant Intraperitoneal/Systemic Chemotherapy (Bidirectional Chemotherapy) for the Treatment of Patients with Peritoneal Metastasis from Gastric Cancer
延伸閱讀
- Bijelic, L., Kumar, A. S., Stuart, O. A., & Sugarbaker, P. H. (2012). Systemic Chemotherapy prior to Cytoreductive Surgery and HIPEC for Carcinomatosis from Appendix Cancer: Impact on Perioperative Outcomes and Short-Term Survival. Gastroenterology Research and Practice, 2012(), 75-80-010. https://doi.org/10.1155/2012/163284
- Ling, M. S., Liang, J. T., Huang, J., & Lin, B. R. (2017). Feasibility of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients with Peritoneal Carcinomatosis from Colorectal Cancerin Short-term Outcome. 中華民國大腸直腸外科醫學會雜誌, 28(1), 27-33. https://doi.org/10.6312/SCRSTW.2017.28(1).10525
- Sugarbaker, P. H. (2012). Cytoreductive Surgery Plus Hyperthermic Perioperative Chemotherapy for Selected Patients with Peritoneal Metastases from Colorectal Cancer: A New Standard of Care or an Experimental Approach?. Gastroenterology Research and Practice, 2012(), 241-249-035. https://doi.org/10.1155/2012/309417
- Adam, A. C., Alderman, R., Stuart, O. A., Chang, D., & Sugarbaker, P. H. (2011). Gastrointestinal Complications in 147 Consecutive Patients with Peritoneal Surface Malignancy Treated by Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy. International Journal of Surgical Oncology, 2011(), 136-145. https://doi.org/10.1155/2011/468698
- Chiang, P. J., Ko, K. H., Meng, E., Cha, T. L., Sun, G. H., Yu, D. S., & Kao, C. C. (2022). Risk and Predictors of Patients Receiving Neoadjuvant Chemotherapy Followed by Radical Cystectomy or Transurethral Resection Alone for Muscle-Invasive Bladder Cancer: A Single-Institute Experience. Journal of Medical Sciences, 42(4), 175-179. https://doi.org/10.4103/jmedsci.jmedsci_112_21